Literature DB >> 18654659

Viability-dependent promoting action of adult neural precursors in spinal cord injury.

Daniele Bottai1, Laura Madaschi, Anna M Di Giulio, Alfredo Gorio.   

Abstract

The aim of the study was the assessment of the effects of adult neural stem cell (NSC) transplantation in a mouse model of spinal cord injury (SCI). The contusion injury was performed by means of the Infinite Horizon Device to allow the generation of reproducible traumatic lesion to the cord. We administered green fluorescent-labeled (GFP-)NSCs either by intravenous (i.v.) injection or by direct transplantation into the spinal cord (intraspinal route). We report that NSCs significantly improved recovery of hind limb function and greatly attenuated secondary degeneration. The i.v. route of NSC administration yielded better recovery than the intraspinal route of administration. About 2% of total i.v.-administered NSCs homed to the spinal cord injury site, and survived almost undifferentiated; thus the positive effect of NSC treatment cannot be ascribed to damaged tissue substitution. The NSCs homing to the injury site triggered, within 48 h, a large increase of the expression of neurotrophic factors and chemokines. One wk after transplantation, exogenous GFP-NSCs still retained their proliferation potential and produced neurospheres when recovered from the lesion site and cultured in vitro. At a later time, GFP-NSC were phagocytated by macrophages. We suggest that the process of triggering the recovery of function might be strongly related to the viability of GFP-NSC, still capable ex vivo of producing neurospheres, and their ability to modify the lesion environment in a positive fashion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18654659      PMCID: PMC2480612          DOI: 10.2119/2008-00077.Bottai

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  41 in total

Review 1.  Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches.

Authors:  Hans Thoenen; Michael Sendtner
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

2.  Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease.

Authors:  P Akerud; P C Holm; G Castelo-Branco; K Sousa; F J Rodriguez; E Arenas
Journal:  Mol Cell Neurosci       Date:  2002-10       Impact factor: 4.314

3.  Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord.

Authors:  Faisal T Sayer; Martin Oudega; Theo Hagg
Journal:  Exp Neurol       Date:  2002-05       Impact factor: 5.330

4.  Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury.

Authors:  Peter Riess; Chen Zhang; Kathryn E Saatman; Helmut L Laurer; Luca G Longhi; Ramesh Raghupathi; Philipp M Lenzlinger; Jonathan Lifshitz; John Boockvar; Edmund Neugebauer; Evan Y Snyder; Tracy K McIntosh
Journal:  Neurosurgery       Date:  2002-10       Impact factor: 4.654

5.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

Authors:  H A Arnett; J Mason; M Marino; K Suzuki; G K Matsushima; J P Ting
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

6.  Transplanted bone marrow generates new neurons in human brains.

Authors:  Eva Mezey; Sharon Key; Georgia Vogelsang; Ildiko Szalayova; G David Lange; Barbara Crain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

7.  Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line.

Authors:  Chang J Huang; Ramin Nazarian; Justin Lee; Paul M Zhao; Araceli Espinosa-Jeffrey; Jean de Vellis
Journal:  Int J Dev Neurosci       Date:  2002 Jun-Aug       Impact factor: 2.457

8.  Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats.

Authors:  Y Ogawa; K Sawamoto; T Miyata; S Miyao; M Watanabe; M Nakamura; B S Bregman; M Koike; Y Uchiyama; Y Toyama; H Okano
Journal:  J Neurosci Res       Date:  2002-09-15       Impact factor: 4.164

9.  Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma.

Authors:  Alfredo Gorio; Necati Gokmen; Serhat Erbayraktar; Osman Yilmaz; Laura Madaschi; Cinzia Cichetti; Anna Maria Di Giulio; Enver Vardar; Anthony Cerami; Michael Brines
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

10.  Multipotent neural stem cells reside into the rostral extension and olfactory bulb of adult rodents.

Authors:  Angela Gritti; Luca Bonfanti; Fiona Doetsch; Isabelle Caille; Arturo Alvarez-Buylla; Daniel A Lim; Rossella Galli; Jose Manuel Garcia Verdugo; Daniel G Herrera; Angelo L Vescovi
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

View more
  21 in total

1.  Neural stem cells grafts decrease neural apoptosis associated with caspase-7 downregulation and BDNF upregulation in rats following spinal cord hemisection.

Authors:  Guan-nan Xia; Yu Zou; You-cui Wang; Qing-jie Xia; Bing-tuan Lu; Ting-hua Wang; Jian-guo Qi
Journal:  Cell Mol Neurobiol       Date:  2013-08-21       Impact factor: 5.046

2.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

Review 3.  A systematic review of cellular transplantation therapies for spinal cord injury.

Authors:  Wolfram Tetzlaff; Elena B Okon; Soheila Karimi-Abdolrezaee; Caitlin E Hill; Joseph S Sparling; Jason R Plemel; Ward T Plunet; Eve C Tsai; Darryl Baptiste; Laura J Smithson; Michael D Kawaja; Michael G Fehlings; Brian K Kwon
Journal:  J Neurotrauma       Date:  2010-04-20       Impact factor: 5.269

Review 4.  Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?

Authors:  Scott A Myers; Andrew N Bankston; Darlene A Burke; Sujata Saraswat Ohri; Scott R Whittemore
Journal:  Exp Neurol       Date:  2016-04-13       Impact factor: 5.330

5.  Neural stem cell transplantation in experimental contusive model of spinal cord injury.

Authors:  Stephana Carelli; Toniella Giallongo; Claudio Gerace; Anthea De Angelis; Michele D Basso; Anna Maria Di Giulio; Alfredo Gorio
Journal:  J Vis Exp       Date:  2014-12-17       Impact factor: 1.355

6.  Early Immunomodulation by Intravenously Transplanted Mesenchymal Stem Cells Promotes Functional Recovery in Spinal Cord Injured Rats.

Authors:  Jung Hwa Seo; In Keun Jang; Hyongbum Kim; Mal Sook Yang; Jong Eun Lee; Hyo Eun Kim; Yong-Woo Eom; Doo-Hoon Lee; Ji Hea Yu; Ji Yeon Kim; Hyun Ok Kim; Sung-Rae Cho
Journal:  Cell Med       Date:  2011-10-01

7.  Systemic injection of neural stem/progenitor cells in mice with chronic EAE.

Authors:  Matteo Donegà; Elena Giusto; Chiara Cossetti; Julia Schaeffer; Stefano Pluchino
Journal:  J Vis Exp       Date:  2014-04-15       Impact factor: 1.355

8.  Current stem cell treatments for spinal cord injury.

Authors:  R Vawda; J Wilcox; Mg Fehlings
Journal:  Indian J Orthop       Date:  2012-01       Impact factor: 1.251

Review 9.  Cellular treatments for spinal cord injury: the time is right for clinical trials.

Authors:  Michael G Fehlings; Reaz Vawda
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 10.  Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials.

Authors:  Elena Giusto; Matteo Donegà; Chiara Cossetti; Stefano Pluchino
Journal:  Exp Neurol       Date:  2013-03-16       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.